NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

On the combo trial it is not clear from LL's slide but PD1 is use concurrent with DC on both arms.

The patients that received neo PD1 + DC + PD1 did substantially worse than patients who received DC + PD1 (w/o the neo PD1). That would be very odd.

Given the P value here is around .37 (the K/M chart can be read point by point and P calculated) one might come to the reasonable conclusion that the difference is just random chance. And if so, the results really mean nothing at this stage.